Alzamend Neuro, Inc. (ALZN) Press Releases https://ir.alzamend.com/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/alzamend/files/theme/images/logo-sm.png Alzamend Neuro, Inc. Logo Equisolve Investor Relations Suite <![CDATA[Alzamend Neuro's Phase 1/2A Lithium Neuroimaging Data Accepted for Poster Presentation at Neuroscience 2026 in Washington, DC]]> https://ir.alzamend.com/news-events/press-releases/detail/103/alzamend-neuros-phase-12a-lithium-neuroimaging-data Thu, 20 Aug 26 08:00:00 -0400 https://ir.alzamend.com/news-events/press-releases/detail/103/alzamend-neuros-phase-12a-lithium-neuroimaging-data <![CDATA[Alzamend Neuro's Phase 1/2A Lithium Imaging Data Accepted for Oral Presentation at ISMRM Workshop on X-Nuclei MR in Barcelona, Spain]]> https://ir.alzamend.com/news-events/press-releases/detail/102/alzamend-neuros-phase-12a-lithium-imaging-data-accepted Tue, 18 Aug 26 08:00:00 -0400 https://ir.alzamend.com/news-events/press-releases/detail/102/alzamend-neuros-phase-12a-lithium-imaging-data-accepted <![CDATA[Alzamend Neuro Announces Initial Closing of Securities Purchase Agreement with Ault Lending]]> https://ir.alzamend.com/news-events/press-releases/detail/101/alzamend-neuro-announces-initial-closing-of-securities Tue, 04 Aug 26 08:00:00 -0400 https://ir.alzamend.com/news-events/press-releases/detail/101/alzamend-neuro-announces-initial-closing-of-securities <![CDATA[Alzamend Neuro Reports Encouraging Pharmacodynamic Data from Phase II Clinical Trial of AL001 "Lithium in Brain" Study in a Trial Conducted at Massachusetts General Hospital]]> https://ir.alzamend.com/news-events/press-releases/detail/100/alzamend-neuro-reports-encouraging-pharmacodynamic-data Tue, 07 Apr 26 08:00:00 -0400 https://ir.alzamend.com/news-events/press-releases/detail/100/alzamend-neuro-reports-encouraging-pharmacodynamic-data <![CDATA[Alzamend Neuro Reports Positive Topline Data from Phase II Clinical Trial of AL001 "Lithium in Brain" Study; AL001 Achieves Bioequivalence and Demonstrates Superior Brain Delivery Across All Measured Brain Regions]]> https://ir.alzamend.com/news-events/press-releases/detail/99/alzamend-neuro-reports-positive-topline-data-from-phase-ii Thu, 26 Mar 26 08:00:00 -0400 https://ir.alzamend.com/news-events/press-releases/detail/99/alzamend-neuro-reports-positive-topline-data-from-phase-ii <![CDATA[Alzamend Neuro Initiates Phase II Clinical Trial of AL001 "Lithium in Brain" Study in Patients with Bipolar Disorder in Collaboration with Massachusetts General Hospital]]> https://ir.alzamend.com/news-events/press-releases/detail/98/alzamend-neuro-initiates-phase-ii-clinical-trial-of-al001 Mon, 16 Mar 26 08:00:00 -0400 https://ir.alzamend.com/news-events/press-releases/detail/98/alzamend-neuro-initiates-phase-ii-clinical-trial-of-al001 <![CDATA[Alzamend Neuro Announces Completion of Clinical Portion of Phase II Clinical Trial of AL001 "Lithium in Brain" Study Conducted at Massachusetts General Hospital]]> https://ir.alzamend.com/news-events/press-releases/detail/97/alzamend-neuro-announces-completion-of-clinical-portion-of Wed, 19 Nov 25 08:00:00 -0500 https://ir.alzamend.com/news-events/press-releases/detail/97/alzamend-neuro-announces-completion-of-clinical-portion-of <![CDATA[Alzamend Neuro to Present at the 2025 Military Health System Research Symposium]]> https://ir.alzamend.com/news-events/press-releases/detail/96/alzamend-neuro-to-present-at-the-2025-military-health Mon, 28 Jul 25 08:00:00 -0400 https://ir.alzamend.com/news-events/press-releases/detail/96/alzamend-neuro-to-present-at-the-2025-military-health <![CDATA[Alzamend Neuro Reports Annual 2025 Financial Results and Provides Update on Clinical Programs]]> https://ir.alzamend.com/news-events/press-releases/detail/95/alzamend-neuro-reports-annual-2025-financial-results-and Wed, 23 Jul 25 08:00:00 -0400 https://ir.alzamend.com/news-events/press-releases/detail/95/alzamend-neuro-reports-annual-2025-financial-results-and <![CDATA[Alzamend Neuro Announces Final Closing of $5 Million Private Placement Months Ahead of Schedule]]> https://ir.alzamend.com/news-events/press-releases/detail/94/alzamend-neuro-announces-final-closing-of-5-million Mon, 16 Jun 25 08:00:00 -0400 https://ir.alzamend.com/news-events/press-releases/detail/94/alzamend-neuro-announces-final-closing-of-5-million